Marriage Counselors in Emporia, KS Accepting Medicare
6 Marriage Counselors found. Showing 1 - 6
 Sarah Denise Madgwick Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2023 W 12th Ave, Emporia, KS 66801 Phone: 620-412-9616 |
Amy D Reed, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
Mrs. Joanna Mclaughlin, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
Sarah Rutledge, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |
Dr. Jayashree George, D.A., LMFT, ATR-BC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 702 Commercial St, Suite 3b, Emporia, KS 66801 Phone: 620-794-0994 |
Keisha Mcclish, TLMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 |
News Archive
SARcode's SAR 1118 Phase 2 data against dry eye to be presented at ARVO meeting
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort Lauderdale, Florida.
Electrostimulation can improve working memory of people in their 70s, study shows
In a groundbreaking study published in Nature Neuroscience, Rob Reinhart, an assistant professor of psychological and brain sciences at Boston University and BU doctoral researcher John Nguyen, demonstrate that electrostimulation can improve the working memory of people in their 70s so that their performance on memory tasks is indistinguishable from that of 20-year-olds.
Enrollment complete in Gemin X Pharmaceuticals' Phase 2 clinical trial of obatoclax for SCLC
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
Spero Health launched to tackle the rising opioid crisis
Spero Health, Inc., a newly formed healthcare organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorder, announced that it has acquired investment growth capital to meet the demand in communities across the country for high-quality, comprehensive and integrated addiction treatment services.
New avatar system could provide quick and effective therapy for schizophrenia
An avatar system that enables people with schizophrenia to control the voice of their hallucinations is being developed by researchers at UCL with support from the Wellcome Trust.
› Verified 5 days ago
Counselors
Psychologists
Dentists
Pharmacists
Clinical Social Workers
Occupational Therapists
Marriage Counselors